bf/NASDAQ:LPTX_icon.jpeg

NASDAQ:LPTX

Leap Therapeutics, Inc.

  • Stock

USD

Last Close

0.41

06/11 22:17

Market Cap

75.00M

Beta: 0.74

Volume Today

217.02K

Avg: 600.93K

PE Ratio

−1.13

PFCF: −1.85

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-25.45M
-
-21.10M
17.08%
-25.63M
21.46%
-29.73M
15.98%
-23.14M
22.17%
-32.90M
42.19%
-27.51M
16.37%
-40.59M
47.51%
-54.60M
34.52%
-81.41M
49.12%
depreciation and amortization
657K
-
474K
27.85%
25K
94.73%
48K
92%
49K
2.08%
47K
4.08%
34K
27.66%
29K
14.71%
16K
44.83%
427K
2,568.75%
deferred income tax
-271K
-
370K
236.53%
-158K
-
20K
112.66%
-3K
115.00%
-738K
24,500%
379K
151.36%
152K
59.89%
-712K
568.42%
stock based compensation
1.66M
-
1.72M
3.43%
45K
97.38%
5.60M
12,344.44%
3.47M
38.05%
3.89M
12.16%
2.62M
32.74%
3.48M
33.05%
5.18M
48.77%
5.13M
1.00%
change in working capital
850K
-
-1.05M
224.12%
-1.01M
4.45%
2.29M
327.58%
871K
62.03%
1.33M
52.81%
-990K
174.38%
1.01M
202.32%
-651K
164.26%
2.51M
485.71%
accounts receivables
643K
-
117K
81.80%
-1.16M
1,090.60%
-1.01M
12.94%
1.30M
229.04%
inventory
-643K
-
-117K
81.80%
1.16M
1,090.60%
1.01M
12.94%
accounts payables
2.27M
-
1.09M
51.79%
368K
66.33%
1.08M
194.57%
-2.60M
339.94%
3.90M
249.94%
945K
75.77%
712K
24.66%
other working capital
850K
-
-1.05M
224.12%
-3.27M
210.43%
1.20M
136.67%
503K
58.12%
247K
50.89%
1.61M
552.23%
-2.89M
279.21%
-1.60M
44.72%
497K
131.14%
other non cash items
4.54M
-
14K
99.69%
1.23M
8,707.14%
-194K
115.73%
-7.30M
3,664.95%
732K
110.02%
634K
13.39%
527K
16.88%
855K
62.24%
30.31M
3,444.68%
net cash provided by operating activities
-18.02M
-
-19.58M
8.68%
-25.34M
29.40%
-22.14M
12.63%
-26.03M
17.60%
-26.90M
3.34%
-25.96M
3.51%
-35.16M
35.44%
-49.04M
39.50%
-43.75M
10.79%
investments in property plant and equipment
-227K
-
-12K
94.71%
-144K
1,100%
-64K
55.56%
-100K
-
acquisitions net
61K
-
15K
-
25K
66.67%
50.36M
-
purchases of investments
-35.39M
-
-418K
98.82%
sales maturities of investments
53K
-
30.05M
56,601.89%
other investing activites
-1.24M
-
9K
100.73%
-1.39M
-
net cash used for investing activites
-36.80M
-
29.69M
180.68%
-144K
100.48%
-64K
55.56%
-85K
-
25K
129.41%
48.97M
-
debt repayment
-641K
-
common stock issued
46.69M
-
49.16M
-
15.03M
69.42%
15.25M
1.46%
48.52M
218.07%
97.22M
100.38%
-210K
100.22%
-29K
86.19%
common stock repurchased
1M
-
-1K
-
dividends paid
-359K
-
-303K
15.60%
other financing activites
198K
-
16K
91.92%
25.62M
160,012.50%
-1.40M
105.47%
872K
162.20%
-437K
150.11%
25.78M
5,999.77%
813K
96.85%
net cash used provided by financing activities
46.89M
-
16K
99.97%
25.62M
160,012.50%
47.76M
86.44%
15.91M
66.70%
14.82M
6.85%
74.00M
399.41%
98.03M
32.49%
-210K
100.21%
-30K
85.71%
effect of forex changes on cash
-193K
-
-30K
84.46%
251K
936.67%
-618K
346.22%
674K
209.06%
-223K
133.09%
115K
151.57%
-33K
128.70%
-162K
390.91%
-43K
73.46%
net change in cash
-8.13M
-
10.10M
224.25%
388K
96.16%
24.94M
6,328.87%
-9.45M
137.90%
-12.39M
31.10%
48.18M
488.77%
62.84M
30.44%
-49.42M
178.63%
5.14M
110.41%
cash at beginning of period
19.00M
-
10.87M
42.78%
405K
96.27%
793K
95.80%
25.74M
3,145.52%
16.28M
36.73%
3.89M
76.11%
52.07M
1,238.24%
114.92M
120.69%
65.50M
43.00%
cash at end of period
10.87M
-
20.97M
92.91%
793K
96.22%
25.74M
3,145.52%
16.28M
36.73%
3.89M
76.11%
52.07M
1,238.24%
114.92M
120.69%
65.50M
43.00%
70.64M
7.85%
operating cash flow
-18.02M
-
-19.58M
8.68%
-25.34M
29.40%
-22.14M
12.63%
-26.03M
17.60%
-26.90M
3.34%
-25.96M
3.51%
-35.16M
35.44%
-49.04M
39.50%
-43.75M
10.79%
capital expenditure
-227K
-
-12K
94.71%
-144K
1,100%
-64K
55.56%
-100K
-
free cash flow
-18.24M
-
-19.59M
7.39%
-25.48M
30.06%
-22.20M
12.87%
-26.03M
17.26%
-27.00M
3.72%
-25.96M
3.87%
-35.16M
35.44%
-49.04M
39.50%
-43.75M
10.79%

All numbers in USD (except ratios and percentages)